You are here: Industry Insights > GI

News List

LBPs may offer hope to IBS patients in the near future, says report europeanpharmaceuticalreview
August 03, 2021
Live biotherapeutic products (LBPs) are expected to help patients with IBS who currently have no US- or EMA-approved treatments.
Some Hospitalized COVID-19 Patients Have Ongoing GI Symptoms drugs
July 15, 2021
Nearly one in five patients hospitalized with COVID-19 has gastrointestinal (GI) symptoms, with persistence of symptoms in some patients for up to six months, according to a study recently published in Clinical Gastroenterology and Hepatology.
Takeda launches IBD medication Kynteles in India expresspharma
July 09, 2020
Used to treat Ulcerative Colitis and Crohn's Disease as well, the drug expands the company’s GI portfolio in the country.
Refined Carbs May Up Insomnia Risk in Postmenopausal Women drugs
December 27, 2019
Diets with a higher glycemic index (GI) may be a risk factor for insomnia in postmenopausal women, according to a study published online December in the American Journal of Clinical Nutrition.
Vitamin D supplements could ease painful IBS symptoms europeanpharmaceuticalreview
April 29, 2019
Researchers find that vitamin D supplements could help to ease painful Irritable Bowel Syndrome symptoms…
Antibe builds case for GI safety of naproxen alternative fiercebiotech
July 09, 2018
Antibe Therapeutics has posted secondary endpoint data from a phase 2b trial of its alternative to nonsteroidal anti-inflammatory drug (NSAID) naproxen.